{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T23:52:53Z","timestamp":1780357973891,"version":"3.54.1"},"reference-count":8,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","ajconline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Cardiology"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.amjcard.2024.05.036","type":"journal-article","created":{"date-parts":[[2024,6,11]],"date-time":"2024-06-11T06:19:06Z","timestamp":1718086746000},"page":"14-16","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Comparing Apixaban With Warfarin for Therapeutic Anticoagulation in Left Ventricular Assist Devices"],"prefix":"10.1016","volume":"224","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1108-7530","authenticated-orcid":false,"given":"Cullen","family":"Soares","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yash","family":"Desai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik","family":"Sorensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynn","family":"Dees","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manjula","family":"Ananthram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert","family":"Hicks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjcard.2024.05.036_bib0001","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.cardfail.2023.01.009","article-title":"HFSA expert consensus statement on the medical management of patients on durable mechanical circulatory support","volume":"29","author":"Trachtenberg","year":"2023","journal-title":"J Card Fail"},{"key":"10.1016\/j.amjcard.2024.05.036_bib0002","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/j.cardfail.2022.10.168","article-title":"Does an alternative anticoagulation strategy for LVAD patients who have had complications improve time-in-therapeutic range?","volume":"29","author":"Meece","year":"2023","journal-title":"J Card Fail"},{"key":"10.1016\/j.amjcard.2024.05.036_bib0003","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1093\/ajhp\/zxac028","article-title":"Apixaban as an alternative to warfarin for patients with a left ventricular assist device","volume":"79","author":"Horn","year":"2022","journal-title":"Am J Health Syst Pharm"},{"key":"10.1016\/j.amjcard.2024.05.036_bib0004","doi-asserted-by":"crossref","first-page":"S48","DOI":"10.1016\/j.healun.2020.01.1223","article-title":"Apixaban in chronic mechanical circulatory support in patients non-compliant to vitamin-K based anticoagulation","volume":"39","author":"Schulte-Eistrup","year":"2020","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.amjcard.2024.05.036_bib0005","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1097\/MAT.0000000000001650","article-title":"Apixaban: alternative anticoagulation for HeartMate 3 ventricular assist device","volume":"68","author":"Whitehouse","year":"2022","journal-title":"ASAIO J"},{"key":"10.1016\/j.amjcard.2024.05.036_bib0006","article-title":"Increased thromboembolic events with dabigatran compared with vitamin K antagonism in left ventricular assist device patients: a randomized controlled pilot trial","volume":"10","author":"Andreas","year":"2017","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.amjcard.2024.05.036_bib0007","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/j.cardfail.2023.10.473","article-title":"Design and rationale for the direct oral anticoagulant apixaban in left ventricular assist devices (DOAC LVAD) study","volume":"30","author":"Dimond","year":"2024","journal-title":"J Card Fail"},{"key":"10.1016\/j.amjcard.2024.05.036_bib0008","doi-asserted-by":"crossref","unstructured":"Netuka I, Tucanova Z, Ivak P, Gregor S, Kolesar DM, Marek T, Melenovsky V, Binova J, Dorazilova Z, Hegarova M, Podolec M, Riha H, Connors JM, Mehra MR. A prospective randomized trial of direct oral anticoagulant therapy with A fully magnetically levitated LVAD: the DOT-HM3 study [Published online April 9, 2024]. Circulation doi:10.1161\/CIRCULATIONAHA.124.069726.","DOI":"10.1161\/CIRCULATIONAHA.124.069726"}],"container-title":["The American Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914924004193?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914924004193?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,21]],"date-time":"2024-11-21T15:10:27Z","timestamp":1732201827000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002914924004193"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":8,"alternative-id":["S0002914924004193"],"URL":"https:\/\/doi.org\/10.1016\/j.amjcard.2024.05.036","relation":{},"ISSN":["0002-9149"],"issn-type":[{"value":"0002-9149","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparing Apixaban With Warfarin for Therapeutic Anticoagulation in Left Ventricular Assist Devices","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjcard.2024.05.036","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}